VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OHI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OHIOmega Healthcare Investors, Inc.
$48.11$14.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOHIFinancials

Omega Healthcare Investors, Inc. (OHI) Financials

30Y historyFree accessUpdated daily

Revenue expansion reached 16.7% in 2026Q1, supported by a recovery in NOI margins to 98.9% following the stabilization of property-level lease structures.

OHI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue1.24B1.2B1.05B949.74M878.24M1.06B892.38M928.83M881.68M908.38M900.83M743.62M504.79M418.71M350.46M292.2M258.32M197.44M193.76M159.56M135.51M109.64M86.97M81.2M122.78M239.3M263.57M121.44M109.31M90.8M73.13M
Revenue Growth %14.19%13.95%10.7%8.14%-17.37%19.1%-3.92%5.35%-2.94%0.84%21.14%47.31%20.56%19.48%19.94%13.12%30.84%1.9%21.44%17.74%23.59%26.07%7.11%-33.86%-48.69%-9.21%117.05%11.09%20.39%24.17%19.1%
Property Operating Expenses180.21M664.93M14.56M15.03M15.5M12.26M12.32M14.93M0000000653K8M20.63M27.6M000000000000
Net Operating Income (NOI)1.06B533.17M1.04B934.72M862.74M1.05B880.07M913.9M881.68M908.38M900.83M743.62M504.79M418.71M350.46M291.55M250.32M176.81M166.16M159.56M135.51M109.64M86.97M81.2M122.78M239.3M263.57M121.44M109.31M90.8M73.13M
NOI Margin %85.45%44.5%98.62%98.42%98.24%98.85%98.62%98.39%100%100%100%100%100%100%100%99.78%96.9%89.55%85.76%100%100%100%100%100%100%100%100%100%100%100%100%
Operating Expenses175.22M-216.27M377.17M445.74M470.47M484.38M427.81M362.15M384.09M593.21M340.87M332.35M159.48M153.03M135.49M153.76M101.39M60.92M61.42M48.53M46.61M33.58M26.88M35.13M112.59M222.07M280.72M29.39M27.48M21.53M17.7M
G&A Expenses62.61M088M81.5M69.4M64.63M59.89M57.87M63.51M47.68M45.87M38.57M25.89M21.59M21.33M19.43M15.05M11.74M11.7M11.09M13.74M8.59M6.21M5.94M6.29M10.38M6.42M6.12M5.4M4.6M4.01M
EBITDA1.13B1.07B964.31M808.65M724.68M908.19M782.18M853.43M778.87M602.76M827.01M621.97M468.57M394.32M327.95M238.13M233.56M160.58M144.63M147.08M121.17M101.34M83.5M71.96M31.46M39.29M6.12M116.25M103.33M52.37M69.12M
EBITDA Margin %90.85%89.7%91.72%85.14%82.52%85.45%87.65%91.88%88.34%66.36%91.81%83.64%92.82%94.18%93.58%81.5%90.41%81.33%74.64%92.18%89.42%92.43%96.01%88.62%25.62%16.42%2.32%95.73%94.53%57.68%94.52%
Depreciation & Amortization329.51M325.25M304.65M319.68M332.41M342.01M329.92M301.68M281.28M287.59M267.06M210.7M123.26M128.65M112.98M100.34M84.62M44.69M39.89M36.06M32.26M25.28M23.4M25.89M21.27M22.07M23.27M24.21M21.5M-16.9M13.69M
D&A / Revenue %26.6%27.15%28.98%33.66%37.85%32.18%36.97%32.48%31.9%31.66%29.65%28.33%24.42%30.72%32.24%34.34%32.76%22.64%20.59%22.6%23.81%23.05%26.91%31.89%17.32%9.22%8.83%19.94%19.67%-18.61%18.72%
Operating Income796.06M749.44M659.66M488.97M392.28M566.17M452.25M551.75M497.59M315.17M559.95M411.27M345.31M265.68M214.97M137.79M148.94M115.89M104.74M111.03M88.91M76.07M60.1M46.06M10.19M17.22M-17.15M92.04M81.83M69.27M55.43M
Operating Margin %64.26%62.55%62.74%51.48%44.67%53.27%50.68%59.4%56.44%34.7%62.16%55.31%68.41%63.45%61.34%47.16%57.66%58.69%54.05%69.58%65.61%69.38%69.1%56.73%8.3%7.2%-6.51%75.8%74.86%76.29%75.79%
Interest Expense4M220.53M221.72M235.53M233.24M234.6M223.39M208.72M201.42M220.24M175.56M183.21M126.87M92.05M106.1M86.9M90.6M39.08M39.75M44.09M00000000000
Interest Coverage-3.83x2.90x2.09x2.87x2.77x1.73x2.65x2.47x1.48x3.19x2.28x2.74x2.87x2.14x1.61x1.64x3.10x2.95x2.53x-----------
Non-Operating Income-92.88M-95.31M17.2M-2.19M-277.11M-84.51M66.54M-814K-345K-10.99M59K-6.46M-2.91M1.11M-11.83M-1.71M-101K-5.3M-12.63M-655K00-26.88M-60.5M-234.17M-452.08M-280.72M-83.61M-52.98M-26K0
Pretax Income672.23M624.22M428.66M255.05M443.4M432.14M168.47M354.79M296.51M105.92M384.33M234.53M221.35M172.52M120.7M52.61M58.44M82.11M77.62M67.59M58.25M39.74M000000000
Pretax Margin %54.26%52.1%40.77%26.85%50.49%40.66%18.88%38.2%33.63%11.66%42.66%31.54%43.85%41.2%34.44%18%22.62%41.59%40.06%42.36%42.99%36.24%0%0%0%0%0%0%0%0%0%
Income Tax16.24M14.75M10.86M6.25M4.56M3.84M4.92M2.84M3.01M3.25M1.41M1.21M000000-72K-7K2.35M2.38M000000000
Effective Tax Rate %2.42%2.36%2.53%2.45%1.03%0.89%2.92%0.8%1.02%3.07%0.37%0.52%0%0%0%0%0%0%-0.09%-0.01%4.03%6%---------
Net Income632.09M590.11M406.33M242.18M426.93M416.74M159.33M341.12M281.58M100.42M366.42M224.52M221.35M172.52M120.7M52.61M58.44M82.11M78.14M69.37M55.7M38.75M-36.72M3.52M-14.65M-16.66M-66.48M19.67M76.2M44.9M34.59M
Net Margin %51.02%49.25%38.65%25.5%48.61%39.21%17.85%36.73%31.94%11.05%40.68%30.19%43.85%41.2%34.44%18%22.62%41.59%40.33%43.48%41.1%35.34%-42.21%4.33%-11.93%-6.96%-25.22%16.2%69.71%49.45%47.3%
Net Income Growth %41.09%45.23%67.78%-43.27%2.44%161.56%-53.29%21.15%180.4%-72.59%63.2%1.43%28.3%42.94%129.44%-9.98%-28.83%5.09%12.63%24.56%43.72%205.55%-1144.23%124.01%12.07%74.95%-437.98%-74.19%69.71%29.81%50.39%
Funds From Operations (FFO)961.6M915.36M710.97M561.86M759.33M758.75M489.25M642.81M562.86M388.01M633.48M435.23M344.61M301.17M233.68M152.94M143.06M126.81M118.03M105.43M87.96M64.03M-13.31M29.41M6.62M5.41M-43.22M43.88M97.7M28M48.28M
FFO Margin %77.62%76.4%67.62%59.16%86.46%71.39%54.83%69.21%63.84%42.71%70.32%58.53%68.27%71.93%66.68%52.34%55.38%64.23%60.91%66.08%64.91%58.4%-15.31%36.22%5.4%2.26%-16.4%36.14%89.38%30.84%66.03%
FFO Growth %107.38%28.75%26.54%-26.01%0.08%55.08%-23.89%14.2%45.06%-38.75%45.55%26.3%14.42%28.88%52.79%6.91%12.82%7.44%11.95%19.86%37.37%580.99%-145.26%344.01%22.46%112.52%-198.49%-55.08%248.93%-42.01%34.12%
FFO per Share3.052.952.632.243.113.112.082.892.681.883.142.412.712.552.161.501.521.521.571.601.501.23-0.290.750.190.27-1.942.234.891.462.81
FFO Payout Ratio %61.48%85.25%96.41%114.6%83.35%84.04%125.15%87.76%93.93%129.53%71.53%82.31%75.01%72.42%77.97%105.85%97.08%86.14%83.09%77.07%76.02%87.07%-369.36%222.6%0%0%-68.59%148.78%62.64%183.57%87.65%
EPS (Diluted)2.011.941.551.001.801.750.681.541.340.511.901.291.741.461.120.460.520.870.940.900.780.49-0.810.09-0.42-0.83-2.220.513.392.162.01
EPS Growth %28.57%25.16%55%-44.44%2.86%157.35%-55.84%14.93%162.75%-73.16%47.29%-25.86%19.18%30.36%143.48%-11.54%-40.23%-7.45%4.44%15.38%59.18%160.49%-1000%121.43%49.4%62.61%-535.29%-84.96%56.94%7.46%40.56%
EPS (Basic)-2.021.571.011.811.760.701.601.410.511.911.301.751.471.120.460.520.870.940.900.780.49-0.810.09-0.42-0.83-2.220.513.392.162.01
Diluted Shares Outstanding315.13M310.7M270.45M250.45M244.29M244.34M235.1M222.13M209.71M206.79M201.63M180.51M127.29M118.1M108.01M102.18M94.24M83.65M75.21M65.89M58.74M52.06M45.33M39.07M34.89M20.03M22.31M19.69M20M19.17M17.2M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Operator Restructuring and Regulation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Expansion Through Portfolio Optimization

As reported in recent financial statements, Omega Healthcare Investors achieved a 16.7% year-over-year revenue growth in 2026Q1, signaling successful integration of restructured assets and improved operator performance, which appears to be driving a sustained upward trajectory in top-line results compared to the more volatile periods observed in 2024.

The consistent revenue growth suggests that the company is effectively navigating the transition of distressed assets to more stable operators. This trend warrants further investigation into whether the current pace of expansion is sustainable or if it remains heavily dependent on non-recurring lease restructuring gains.

FFO Growth Outpacing Operational Volatility

Based on the provided quarterly data, FFO per share climbed to $0.75 in 2026Q1, reflecting a 24.5% growth rate that suggests the company is successfully insulating its core earnings from the underlying property-level disruptions that have historically plagued the skilled nursing facility sector's financial reporting.

The divergence between FFO growth and the more erratic GAAP net income figures highlights the importance of focusing on cash-based metrics for this REIT. Investors should monitor whether this FFO trajectory can be maintained if operator rent coverage ratios face further pressure from rising labor costs.

NOI Margin Stability Amid Restructuring

According to the latest quarterly filings, Omega maintained a robust NOI margin of 98.9% in 2026Q1, a significant recovery from the 47.2% margin observed in 2025Q4, which appears to indicate that the company has largely stabilized its property-level cost structure following recent portfolio-wide lease adjustments.

The high NOI margin is characteristic of the triple-net lease model, where the majority of operating expenses are shifted to the tenant. However, the sharp fluctuation in 2025Q4 suggests that accounting adjustments related to operator support or non-accrual status can temporarily distort these margins, necessitating a cautious interpretation of quarterly margin performance.

Accounting Nuance Masks Underlying Risks

As indicated by the historical data, the reliance on straight-line rent and the potential for future non-accrual events suggest that reported earnings may overstate true cash collectability, particularly as the company continues to navigate the complex financial health of its largest skilled nursing facility operators.

The presence of significant non-cash adjustments in the income statement implies that investors should look beyond headline FFO to assess the actual cash flow available for dividends. The potential for future rent concessions or operator defaults remains a latent risk that could lead to sudden downward revisions in earnings quality.

OHI — Frequently Asked Questions

Quick answers to the most common questions about buying OHI stock.

What was Omega Healthcare Investors, Inc.'s (OHI) revenue in 2025?

For fiscal year 2025, Omega Healthcare Investors, Inc. (OHI) reported total revenue of $1.20B. This represents a 1538.4% increase compared to $73.1M in 1996.

Is Omega Healthcare Investors, Inc. (OHI) profitable?

Omega Healthcare Investors, Inc. (OHI) is profitable, generating $590.1M in net income for the fiscal year ending 2025 with a net profit margin of 49.3%.

What is Omega Healthcare Investors, Inc.'s operating profit margin?

Omega Healthcare Investors, Inc. (OHI) reported an operating income of $749.4M, resulting in an operating profit margin of 62.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Omega Healthcare Investors, Inc.'s gross profit and gross margin?

Omega Healthcare Investors, Inc. (OHI) generated $533.2M in gross profit for the year, representing a gross profit margin of 44.5%. This demonstrates the company's core pricing power and production efficiency.